Trial intelligence / Profile preview

ESRA study of H1N1 vaccine immunogenicity in rituximab-treated rheumatoid arthritis

NL-OMON28264Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Nov 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Open-label trial of influenza A (H1N1) 2009 monovalent vaccine in influenza A virus infection (H1N1), sponsored by Amsterdam University Medical Center. Started Nov 2009; status: active, not recruiting.

02

Drugs

influenza A (H1N1) 2009 monovalent vaccine
03

Conditions

influenza A virus infection (H1N1)

Beyond the preview

Go deeper on NL-OMON28264.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON28264.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call